| Literature DB >> 29379289 |
Shanaya Rathod1, Lina Gega2, Amy Degnan3, Jennifer Pikard4, Tasneem Khan5, Nusrat Husain3, Tariq Munshi4, Farooq Naeem4.
Abstract
In recent years, there has been a steadily increasing recognition of the need to improve the cultural competence of services and cultural adaptation of interventions so that every individual can benefit from evidence-based care. There have been attempts at culturally adapting evidence-based interventions for mental health problems, and a few meta-analyses have been published in this area. This is, however, a much debated subject. Furthermore, there is a lack of a comprehensive review of meta-analyses and literature reviews that provide guidance to policy makers and clinicians. This review summarizes the current meta-analysis literature on culturally adapted interventions for mental health disorders to provide a succinct account of the current state of knowledge in this area, limitations, and guidance for the future research.Entities:
Keywords: cultural adaptation; interventions; mental illness; meta-analysis; minority ethnic; psychotherapies
Year: 2018 PMID: 29379289 PMCID: PMC5757988 DOI: 10.2147/NDT.S138430
Source DB: PubMed Journal: Neuropsychiatr Dis Treat ISSN: 1176-6328 Impact factor: 2.570
Figure 1PRISMA flow chart.
Notes: Moher D, Liberati A, Tetzlaff J, Altman DG; The PRISMA Group (2009). Preferred reporting items for systematic reviews and meta-analyses: The PRISMA Statement. PLoS Med. 6(6):e1000097.32
Findings from review of meta-analysis of culturally adapted interventions
| Author | Study characteristics | Participant characteristics | Results and methodological rigor | Cultural adaptation, moderators, comments |
|---|---|---|---|---|
| Griner and Smith | N=76 studies | N=25,225 | Effect size = d=0.45 (SE =0.04, | Cultural adaptation = Attempted but inadequately reported (not consistently conducted) |
| Huey and Polo | Number =25 studies | N=1,056 | Heterogeneity analysis = Effect size at 4–6 months (d=0.36), 1–1.17 years (d=0.28), 4 years (d=0.68), and 13.7 years (d=0.37). Effect sizes higher with no control conditions (d=0.58); cf placebo (d=0.51) and TAU (d=0.22) | No moderating effect for ethnicity, problem type, clinical severity, diagnostic status, and culture-responsive treatment |
| Hodge et al | N=21 studies | Age ≤18 years | Effect size = Adapted interventions an aggregate standardized mean difference of 0.240 compared to those not participating in CSIs (Hedge’s g=0.239, 95% CI =0.139–0.339, | No moderating effect of race or ethnicity Overall results suggest that CSIs are minimally effective with minority youths |
| Smith et al | N=65 | N=8,620 | Effect size = Weighted average effect size was d=0.46 (95% CI =0.36–0.56) (effect size using “trim and fill” methodology; | Age (average age) was strongly associated with the magnitude of effect sizes within studies, and ethnicity (studies with Asian American had an average effect size of more than twice that of 14 studies of African American participants [d=0.47], Hispanic/Latino(a) [d=0.47], and Native American participants [d=0.22]) Specific cultural group versus mixed ethnic group (interventions delivered to a specific cultural group were much more effective [d=0.51, 95% CI =0.40–0.63] than interventions delivered to mixed groups [d=0.18, 95% CI =−0.08 to 0.44]) |
| Benish et al | N=59 (21 studies that compared adapted versus unadapted therapy) | N=1,242 | Effect size = For analysis 1 aggregated effect size d=0.41 for primary measures and 0.33 for all measures. For analysis 2 aggregated effect size d=0.32 for primary measures | The conditional model with myth adaptation as a Level 2 predictor revealed that adaptation of the myth was significant ( |
| Chowdhary et al | N=16 studies | N=4,162 | Effect size = SMD =−0.72, 95% CI =−0.94 to −0.49 | Cultural adaptation – MRC Guidelines |
| Rojas-García et al | N=11 studies (16 used in the review) | N=864 | Effect size = 0.44, 95% CI =−0.67 to −0.22 | Individually administered interventions (higher effectiveness [−0.79, 95% CI =1.16 to −0.43]), cf group-administered interventions (−0.30, 95% CI =−0.53 to 0.07), interventions conducted in hospitals/clinics (0.61, 95% CI =−0.90 to −0.32) and at home (−0.68, 95% CI =−1.20 to −0.17); those conducted after birth (−0.82, 95% CI =−1.26 to −0.38); those based on psychoeducation (−0.81, 95% CI =−1.23 to −0.39) and IPT (−0.51, 95% CI =−0.92 to −0.10), and those that were culturally adapted (−0.54, 95% CI =−0.78 to −0.29) had more effect |
| Rojas-García et al | N=15 studies (13 interventions) | N=2,261 | Effect size = For short term (upto 3 months) −0.58, 95% CI =−0.74 to −0.41, and for long term −0.42, 95% CI =−0.63 to −0.21 | Culturally specific training for providers/therapists and booster sessions improved the effectiveness of the interventions. Use of peer providers and the provision of extra services helped to facilitate adherence to the intervention |
| Sutton | N=49 studies | N = Unknown | Effect size = For mental health outcomes d=0.58 (CI =0.33–0.83) using the random-effects model and d=0.37 (CI =0.31–0.43) using the fixed-effects model | The type of cultural adaptation (ie, surface, deep, or combined structure) does not appear to moderate outcomes. Acculturation, the immigration status of the study participants, the primary language of intervention, treatment style and format, and construct categories of mental health did not influence effectiveness of adapted interventions. However, moderators were noted in overall health outcomes (i.e., mean age of participants in mixed age groups), aggregated mental health outcomes (i.e., South American participant ethnicity), and aggregated physical health outcomes (i.e., mean age of both younger and older participants in mixed age groups and Cuban participant ethnicity) |
| van Loon et al | N=9 studies | Age = U | Effect size = Pooled random standardized difference in means on clinical outcome was 1.06 (95% CI =0.51–1.62, | Cultural adaptation works if combined with a focus on patients |
| Type = Effectiveness | Target problems = Anxiety or depressive problems were described as phobic, panic disorder, posttraumatic stress disorder, major depressive disorder, risk for stress and depression, risk for perinatal depression, and probable depression | Heterogeneity analysis = Considerable heterogeneity among studies | cultural values, beliefs, and symptom presentation | |
| Hall et al | N=78 studies | N=13,998 | Effect size = Random-effects multilevel regression model, overall effect size (g=0.67, | Language of intervention; therapist ethnicity; whether therapy adaptation was top–down or bottom–up moderate effect |
| Degnan et al | N=46 studies (43 trials) | N=7,828 | Effect size = Pooled weighted SMDs using random-effects models for total symptoms g =−0.23, CI =−0.36 to −0.09; positive symptoms g =−0.56, CI =−0.86 to −0.26; negative symptoms g =−0.39, CI =−0.63 to −0.15; and general psychopathology g =0.75, CI =−1.21 to −0.29 | Cultural adaptations studied using qualitative research. Adaptations were grouped into nine themes: language, concepts, family, communication, content, cultural norms and practices, context and delivery, therapeutic alliance, and treatment goals |
Abbreviations: TAU, treatment as usual; IPT, interpersonal therapy; PST, problem solving therapy; DOT, dynamically oriented art group therapy; MRC, Medical Research Council framework; CSI, culturally sensitive interventions; SMD, serious mental disorders; PT, psychological therapies; FI, family intervention; PE, psychoeducation; CBT, cognitive behavioral therapy; MCT, metacognitive therapy; IMR, illness management and recovery; SST, social skills training; U, uncertain; N/A, not available.
Quality assessment of included reviews using AMSTAR* criteria
| Review (author) | 1. Was a priori design provided? | 2. Was there duplicate study selection and data extraction? | 3. Was a comprehensive literature search performed? | 4. Was the status of publication (ie, gray literature) used as an inclusion criterion? | 5. Was a list of studies (included and excluded) provided? | 6. Were the characteristics of the included studies provided? | 7. Was the scientific quality of the included studies assessed and documented? | 8. Was the scientific quality of the included studies used appropriately in formulating conclusions? | 9. Were the methods used to combine the findings of studies appropriate? | 10. Was the likelihood of publication bias assessed? | 11. Was the conflict of interest included? | Global quality of meta-analysis |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Griner and Smith | Y | U | Y | U | N | Y | Y | Y | Y | Y | N | 7 |
| Huey and Polo | Y | N | N | N | Y | Y | Y | Y | Y | Y | N | 7 |
| Hodge et al | Y | Y | Y | Y | Y | Y | Y | Y | Y | Y | N | 8 |
| Smith et al | Y | Y | Y | Y | N | Y | Y | U | U | Y | N | 7 |
| Benish et al | Y | N | Y | Y | N | Y | N | U | Y | U | N | 8 |
| Chowdhary et al | Y | Y | Y | U | Y | Y | Y | Y | Y | Y | N | 8 |
| Rojas-García et al | Y | U | Y | N | Y | Y | Y | U | Y | Y | N | 7 |
| Rojas-García et al | Y | U | Y | Y | Y | Y | Y | U | Y | Y | N | 8 |
| Sutton | Y | U | Y | Y | N | Y | Y | U | U | Y | N | 6 |
| van Loon et al | Y | U | Y | N | Y | Y | Y | U | U | Y | N | 6 |
| Hall et al | Y | N | Y | Y | N | Y | Y | U | U | Y | N | 6 |
| Degnan et al | Y | Y | Y | Y | N | Y | Y | Y | Y | Y | N | 9 |
Notes: Indicate whether each criterion is met: Yes (Y), No (N), Uncertain (U). Quality of meta-analyses assessed using a scale of 0–10, where 0 is poor and 10 is excellent.
Assessment of Multiple SysTemAtic Reviews (AMSTAR) criteria (*Shea BJ, Hamel C, Wells GA, et al. AMSTAR is a reliable and valid measurement tool to assess the methodological quality of systematic reviews. J Clin Epidem. 2009;62(10):1013–1020).
1. Was a priori design provided? The research question and inclusion criteria should be established before the conduct of the review.
2. Was there duplicate study selection and data extraction? There should be at least two independent data extractors and a consensus procedure for disagreements should be in place.
3. Was a comprehensive literature search performed? At least two electronic sources should be searched. The report must include years and databases used (eg, Central, EMBASE, and MEDLINE). Key words and/or MESH terms must be stated and where feasible the search strategy should be provided. All searches should be supplemented by consulting current contents, reviews, textbooks, specialized registers, or experts in the particular field of study, and by reviewing the references in the studies found.
4. Was the status of publication (ie, gray literature) used as an inclusion criterion? The authors should state that they searched for reports regardless of their publication type. The authors should state whether or not they excluded any reports (from the systematic review), based on their publication status, language, and so on.
5. Was a list of studies (included and excluded) provided? A list of included and excluded studies should be provided.
6. Were the characteristics of the included studies provided? In an aggregated form such as a table, data from the original studies should be provided on the participants, interventions, and outcomes. The ranges of characteristics in all the studies analyzed, for example, age, race, sex, relevant socioeconomic data, disease status, duration, severity, or other diseases, should be reported.
7. Was the scientific quality of the included studies assessed and documented? A priori methods of assessment should be provided (eg, for effectiveness studies if the author(s) chose to include only randomized, double-blind, placebo-controlled studies, or allocation concealment as inclusion criteria); for other types of studies alternative items will be relevant.
8. Was the scientific quality of the included studies used appropriately in formulating conclusions? The results of the methodological rigor and scientific quality should be considered in the analysis and the conclusions of the review, and explicitly stated in formulating recommendations.
9. Were the methods used to combine the findings of studies appropriate? For the pooled results, a test should be done to ensure the studies were combinable, to assess their homogeneity (ie, Chi-squared test for homogeneity, I2). If heterogeneity exists, a random-effects model should be used and/or the clinical appropriateness of combining should be taken into consideration (ie, is it sensible to combine?).
10. Was the likelihood of publication bias assessed? An assessment of publication bias should include a combination of graphical aids (eg, funnel plot, other available tests) and/or statistical tests (eg, Egger regression test).
11. Was the conflict of interest included? Potential sources of support should be clearly acknowledged in both the systematic review and the included studies.